Literature DB >> 1121419

Production of the features of Reye's syndrome in rats with 4-pentenoic acid.

A M Glasgow, H P Chase.   

Abstract

4-Pentenoic acid, an analog of hypoglycin which is believed to cause Jamaican vomiting sickness, was administered intraperitoneally to rats in an attempt to produce the features of Reye's syndrome in rats. Mean ammonia levels in plasma were found to be elevated approximately four-fold after injection of 200 mg/kg pentenoic acid in fed rats. Pentenoic acid caused hypoglycemia in fasted rats and hyperglycemia in fed rats. In chronic experiments rats were injected intraperitoneally every 4 hr with 50 mg/kg body weight of pentenoic acid for 10 doses, followed by a single dose of 200 mg/kg. The livers of the treated group were enlarged and yellow and showed extensive fatty degeneration. The blood-urea-nitrogen (BUN) was significantly higher and the free fatty acids (FFA's) significantly lower in these rats. This study shows that pentenoic acid administered to rats produces findings similar to those of Reye's syndrome and Jamaican vomiting sickness.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1121419     DOI: 10.1203/00006450-197503000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  17 in total

1.  Fatty liver: biochemical and clinical considerations.

Authors:  A M Hoyumpa; H L Greene; G D Dunn; S Schenker
Journal:  Am J Dig Dis       Date:  1975-12

2.  Effect of pent-4-enoic acid, propionic acid and other short-chain fatty acids on citrulline synthesis in rat liver mitochondria.

Authors:  A M Glasgow; H P Chase
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

Review 3.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

4.  Reye's syndrome.

Authors:  D A Trauner
Journal:  West J Med       Date:  1984-08

5.  Decreased serum carnitine in valproate induced Reye syndrome.

Authors:  H Böhles; K Richter; E Wagner-Thiessen; H Schäfer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

Review 6.  Hepatotoxicity to sodium valproate: a review.

Authors:  P R Powell-Jackson; J M Tredger; R Williams
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

7.  Isolated rat heart mitochondria are able to metabolize pent-4-enoate to tricarboxylic acid-cycle intermediates.

Authors:  J K Hiltunen; R A Kauppinen; E M Nuutinen; K J Peuhkurinen; I E Hassinen
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

8.  Serum lipid abnormalities in a chemical/viral mouse model for Reye's syndrome.

Authors:  M G Murphy; L Archambault-Schertzer; R G Ackman; J F Crocker
Journal:  Lipids       Date:  1986-06       Impact factor: 1.880

9.  Abnormal metabolism of valproic acid in fatal hepatic failure.

Authors:  W Kochen; A Schneider; A Ritz
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

Review 10.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.